131 related articles for article (PubMed ID: 3357417)
1. The effect of abnormal plasma and cellular sterol content and composition on low density lipoprotein uptake and degradation by monocytes and lymphocytes in sitosterolemia with xanthomatosis.
Nguyen LB; Shefer S; Salen G; Horak I; Tint GS; McNamara DJ
Metabolism; 1988 Apr; 37(4):346-51. PubMed ID: 3357417
[TBL] [Abstract][Full Text] [Related]
2. Unexpected failure of bile acid malabsorption to stimulate cholesterol synthesis in sitosterolemia with xanthomatosis. Comparison with lovastatin.
Nguyen L; Salen G; Shefer S; Shore V; Tint GS; Ness G
Arteriosclerosis; 1990; 10(2):289-97. PubMed ID: 2317163
[TBL] [Abstract][Full Text] [Related]
3. A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis.
Nguyen LB; Shefer S; Salen G; Ness GC; Tint GS; Zaki FG; Rani I
J Clin Invest; 1990 Sep; 86(3):923-31. PubMed ID: 2394840
[TBL] [Abstract][Full Text] [Related]
4. Decreased cholesterol biosynthesis in sitosterolemia with xanthomatosis: diminished mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and enzyme protein associated with increased low-density lipoprotein receptor function.
Nguyen LB; Salen G; Shefer S; Tint GS; Shore V; Ness GC
Metabolism; 1990 Apr; 39(4):436-43. PubMed ID: 2325562
[TBL] [Abstract][Full Text] [Related]
5. Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis.
Gregg RE; Connor WE; Lin DS; Brewer HB
J Clin Invest; 1986 Jun; 77(6):1864-72. PubMed ID: 3711338
[TBL] [Abstract][Full Text] [Related]
6. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis.
Salen G; Shore V; Tint GS; Forte T; Shefer S; Horak I; Horak E; Dayal B; Nguyen L; Batta AK
J Lipid Res; 1989 Sep; 30(9):1319-30. PubMed ID: 2600539
[TBL] [Abstract][Full Text] [Related]
7. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis.
Salen G; Horak I; Rothkopf M; Cohen JL; Speck J; Tint GS; Shore V; Dayal B; Chen T; Shefer S
J Lipid Res; 1985 Sep; 26(9):1126-33. PubMed ID: 4067433
[TBL] [Abstract][Full Text] [Related]
8. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters.
Bhattacharyya AK; Connor WE
J Clin Invest; 1974 Apr; 53(4):1033-43. PubMed ID: 4360855
[TBL] [Abstract][Full Text] [Related]
9. Macrophage 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in sitosterolemia: effects of increased cellular cholesterol and sitosterol concentrations.
Nguyen LB; Salen G; Shefer S; Tint GS; Ruiz F
Metabolism; 2001 Oct; 50(10):1224-9. PubMed ID: 11586498
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction.
Nguyen LB; Cobb M; Shefer S; Salen G; Ness GC; Tint GS
J Lipid Res; 1991 Dec; 32(12):1941-8. PubMed ID: 1816322
[TBL] [Abstract][Full Text] [Related]
11. A marked and sustained reduction in LDL sterols by diet and cholestyramine in beta-sitosterolemia.
Parsons HG; Jamal R; Baylis B; Dias VC; Roncari D
Clin Invest Med; 1995 Oct; 18(5):389-400. PubMed ID: 8529322
[TBL] [Abstract][Full Text] [Related]
12. Competitive inhibition of hepatic sterol 27-hydroxylase by sitosterol: decreased activity in sitosterolemia.
Nguyen LB; Shefer S; Salen G; Tint SG; Batta AK
Proc Assoc Am Physicians; 1998; 110(1):32-9. PubMed ID: 9460081
[TBL] [Abstract][Full Text] [Related]
13. Inverse relationship between plasma cholestanol concentrations and bile acid synthesis in sitosterolemia.
Salen G; Batta AK; Tint GS; Shefer S; Ness GC
J Lipid Res; 1994 Oct; 35(10):1878-87. PubMed ID: 7852865
[TBL] [Abstract][Full Text] [Related]
14. Sluggish sitosterol turnover and hepatic failure to excrete sitosterol into bile cause expansion of body pool of sitosterol in patients with sitosterolemia and xanthomatosis.
Bhattacharyya AK; Connor WE; Lin DS; McMurry MM; Shulman RS
Arterioscler Thromb; 1991; 11(5):1287-94. PubMed ID: 1911714
[TBL] [Abstract][Full Text] [Related]
15. Comparative effect of dietary sitosterol on plasma sterols and cholesterol and bile acid synthesis in a sitosterolemic homozygote and heterozygote subject.
Cobb MM; Salen G; Tint GS
J Am Coll Nutr; 1997 Dec; 16(6):605-13. PubMed ID: 9430090
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.
Salen G; Kwiterovich PO; Shefer S; Tint GS; Horak I; Shore V; Dayal B; Horak E
J Lipid Res; 1985 Feb; 26(2):203-9. PubMed ID: 3989379
[TBL] [Abstract][Full Text] [Related]
17. Current therapy for patients with sitosterolemia--effect of ezetimibe on plant sterol metabolism.
Tsubakio-Yamamoto K; Nishida M; Nakagawa-Toyama Y; Masuda D; Ohama T; Yamashita S
J Atheroscler Thromb; 2010 Sep; 17(9):891-900. PubMed ID: 20543520
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoproteins modified by lipid transfer protein have altered biological activity.
Chait A; Eisenberg S; Steinmetz A; Albers JJ; Bierman EL
Biochim Biophys Acta; 1984 Sep; 795(2):314-25. PubMed ID: 6477948
[TBL] [Abstract][Full Text] [Related]
19. Surface binding and catabolism of low-density lipoprotein by circulating lymphocytes from patients with abetalipoproteinaemia, with observations on sterol synthesis in lymphocytes from one patient.
Reichl D; Myant NB; Lloyd JK
Biochim Biophys Acta; 1978 Jul; 530(1):124-31. PubMed ID: 210827
[TBL] [Abstract][Full Text] [Related]
20. Receptor activities for low-density lipoprotein and acetylated low-density lipoprotein in a mouse macrophage cell line (IC21) and in human monocyte-derived macrophages.
Traber MG; Defendi V; Kayden HJ
J Exp Med; 1981 Dec; 154(6):1852-67. PubMed ID: 6274992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
